Evidence map›Paper›PMID 36160325›Full record

ReviewScanning2022

Update Research Advances in the Application of Transcranial Magnetic Stimulation in the Treatment of Schizophrenia.

Yanhai Wu, Zucheng Yang, Shu Cui

Abstract readReview
In one paragraph

Review in Scanning, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yanhai WuThe Third People's Hospital of Fuyang, Fuyang 236000, China.ORCID https://orcid.org/0000-0001-7473-8049
Zucheng YangAnhui Province Veterans Hospital, Bengbu 233000, China.ORCID https://orcid.org/0000-0002-5092-8515
Shu CuiThe Third People's Hospital of Fuyang, Fuyang 236000, China.ORCID https://orcid.org/0000-0003-0148-7319

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia presents a chronic progressive course and requires long-term treatment. The current treatment of schizophrenia is mainly based on antipsychotic drugs, but drugs are ineffective for the negative symptoms and cognitive dysfunction of schizophrenia, and long-term medication may increase the burden on the endocrine and circulatory systems of patients. Repetitive transcranial magnetic stimulation is a noninvasive, painless, safe, efficacious, and economical physical therapy measure that has achieved good results in the treatment of schizophrenia. This paper reviews the progress of research on the clinical application of transcranial magnetic stimulation in the treatment of schizophrenia.

Indexed as

Antipsychotic AgentsSchizophreniaHumansTranscranial Magnetic StimulationAntipsychotic Agents

Identifiers

PMID36160325
PMCPMC9484979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.